SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-041873
Filing Date
2023-11-17
Accepted
2023-11-17 16:05:38
Documents
16
Period of Report
2023-11-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm   iXBRL 8-K 42214
2 ex3-1.htm EX-3.1 1650
3 ex99-1.htm EX-99.1 8518
4 ex3-1_001.jpg GRAPHIC 109117
5 ex3-1_002.jpg GRAPHIC 287603
  Complete submission text file 0001493152-23-041873.txt   780108

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE thar-20231117.xsd EX-101.SCH 3021
7 XBRL LABEL FILE thar-20231117_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE thar-20231117_pre.xml EX-101.PRE 22363
10 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3508
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 231418608
SIC: 2834 Pharmaceutical Preparations